Insider Buying: agilon health, inc. (NYSE:AGL) Director Acquires 7,500 Shares of Stock

agilon health, inc. (NYSE:AGL) Director Diana Mckenzie acquired 7,500 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was purchased at an average cost of $2.20 per share, for a total transaction of $16,500.00. Following the completion of the acquisition, the director now directly owns 58,819 shares of the company’s stock, valued at approximately $129,401.80. This trade represents a 14.61 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this link.

Diana Mckenzie also recently made the following trade(s):

• On Monday, November 25th, Diana Mckenzie bought 12,500 shares of agilon health stock. The stock was purchased at an average price of $2.28 per share, for a total transaction of $28,500.00.

agilon health Price Performance

Shares of NYSE AGL opened at $2.25 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a fifty day moving average of $2.44 and a 200 day moving average of $4.40. The firm has a market cap of $927.04 million, a PE ratio of -2.39 and a beta of 0.51. agilon health, inc. has a one year low of $1.50 and a one year high of $13.76.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the prior year, the firm earned ($0.06) EPS. As a group, research analysts predict that agilon health, inc. will post -0.52 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on AGL shares. Barclays reduced their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research report on Monday, November 11th. JMP Securities downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. TD Cowen cut their price target on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. William Blair cut agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $3.00 target price on shares of agilon health in a report on Tuesday, November 19th. Three analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $4.38.

Hedge Funds Weigh In On agilon health

Hedge funds and other institutional investors have recently made changes to their positions in the company. J.Safra Asset Management Corp raised its position in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after buying an additional 3,625 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in agilon health in the 3rd quarter valued at about $28,000. CWM LLC lifted its stake in agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after purchasing an additional 7,288 shares in the last quarter. Nisa Investment Advisors LLC purchased a new position in agilon health in the 2nd quarter worth approximately $60,000. Finally, Allspring Global Investments Holdings LLC boosted its holdings in shares of agilon health by 17,790.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock worth $70,000 after purchasing an additional 10,674 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.